These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16390229)

  • 1. Testing in cervicovaginal cytology.
    Koss LG
    Arch Pathol Lab Med; 2006 Jan; 130(1):13. PubMed ID: 16390229
    [No Abstract]   [Full Text] [Related]  

  • 2. How expert are the experts? Implications for proficiency testing in cervicovaginal cytology.
    Ducatman BS; Ducatman AM
    Arch Pathol Lab Med; 2005 May; 129(5):604-5. PubMed ID: 15859628
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of field validation in the interlaboratory comparison program in cervicovaginal cytology.
    Oxley DK
    Arch Pathol Lab Med; 2006 Feb; 130(2):144; author reply 144-5. PubMed ID: 16454546
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytologic features of adenocarcinoma, not otherwise specified, in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology.
    Renshaw AA; Schwartz MR; Wang E; Haja J; Hughes JH
    Arch Pathol Lab Med; 2006 Jan; 130(1):23-6. PubMed ID: 16390233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the significance of participant evaluation of acceptability of cases in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology.
    Renshaw AA; Mody DR; Wang E; Wilbur DC; Colgan TJ;
    Arch Pathol Lab Med; 2005 Sep; 129(9):1093-6. PubMed ID: 16119978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytologic features of squamous cell carcinoma in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology.
    Renshaw AA; Henry MR; Birdsong GG; Wang E; Haja J; Hughes JH
    Arch Pathol Lab Med; 2005 Sep; 129(9):1097-9. PubMed ID: 16119979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria: results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program.
    ; Young NA; Moriarty AT; Walsh MK; Wang E; Wilbur DC
    Arch Pathol Lab Med; 2006 Aug; 130(8):1114-8. PubMed ID: 16879010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of herpes simplex challenges in proficiency testing: observations from the College of American Pathologists proficiency testing program.
    Moriarty AT; Darragh TM; Souers R; Fatheree LA; Wilbur DC
    Arch Pathol Lab Med; 2009 Sep; 133(9):1379-82. PubMed ID: 19722743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical Cytology Practice Guidelines. American Society of Cytopathology.
    Cortese C;
    Acta Cytol; 2001; 45(2):201-26. PubMed ID: 11284307
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts?
    Renshaw AA; Wang E; Mody DR; Wilbur DC; Davey DD; Colgan TJ;
    Arch Pathol Lab Med; 2005 May; 129(5):609-13. PubMed ID: 15859630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pap smear liability: do computer-assisted rescreening devices affect the standard of care?
    Bierig JR; Weber SA
    CAP Today; 1997 Apr; 11(4):32-4. PubMed ID: 10174223
    [No Abstract]   [Full Text] [Related]  

  • 12. College of American Pathologists Conference XXX on quality and liability issues with the Papanicolaou smear: introduction.
    Austin RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):227-8. PubMed ID: 9111105
    [No Abstract]   [Full Text] [Related]  

  • 13. Papanicolaou smear 5-year retrospective review: what is required by the Clinical Laboratory Improvement Amendments of 1988?
    Davey DD
    Arch Pathol Lab Med; 1997 Mar; 121(3):296-8. PubMed ID: 9111122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blinded review of Papanicolaou smears.
    Gill GW
    Cancer; 2005 Apr; 105(2):53-5. PubMed ID: 15662699
    [No Abstract]   [Full Text] [Related]  

  • 15. Appeals in gynecologic cytology proficiency testing: review and analysis of data from the 2006 College of American Pathologists gynecologic cytology proficiency testing program.
    Crothers BA; Moriarty AT; Fatheree LA; Booth CN; Tench WD; Wilbur DC;
    Arch Pathol Lab Med; 2009 Jan; 133(1):44-8. PubMed ID: 19123735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal quality assurance in cervical cytology one laboratory's experience.
    Cross PA
    Cytopathology; 1996 Feb; 7(1):25-31. PubMed ID: 8833871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopathology laboratory improvement programs of the College of American Pathologists: Laboratory Accreditation Program (CAP LAP) and Performance Improvement Program in Cervicovaginal Cytology (CAP PAP).
    Nielsen ML
    Arch Pathol Lab Med; 1997 Mar; 121(3):256-9. PubMed ID: 9111112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatic failure in gynecologic cytology proficiency testing. Results from the College of American Pathologists proficiency testing program.
    Moriarty AT; Crothers BA; Bentz JS; Souers RJ; Fatheree LA; Wilbur DC
    Arch Pathol Lab Med; 2009 Nov; 133(11):1757-60. PubMed ID: 19886708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspects in quality assurance in gynecological cytology].
    Hilgarth M
    Gynakologe; 1990 Dec; 23(6):312-8. PubMed ID: 2279705
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.